Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide

Imagem de Miniatura
Arquivos
art_CHEN_Human_Papillomavirus_45_Genetic_Variation_and_Cervical_Cancer_2014.PDF (905.02 KB)
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC MICROBIOLOGY
Autores
CHEN, Alyce A.
HEIDEMAN, Danielle A. M.
BOON, Debby
GHEIT, Tarik
SNIJDERS, Peter J. F.
TOMMASINO, Massimo
FRANCESCHI, Silvia
CLIFFORD, Gary M.
Citação
JOURNAL OF VIROLOGY, v.88, n.8, p.4514-4521, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human papillomavirus 45 (HPV45) is a member of the HPV18-related alpha-7 species and accounts for approximately 5% of all cervical cancer cases worldwide. This study evaluated the genetic diversity of HPV45 and the association of HPV45 variants with the risk of cervical cancer by sequencing the entire E6 and E7 open reading frames of 300 HPV45-positive cervical samples from 36 countries. A total of 43 HPV45 sequence variants were identified that formed 5 phylogenetic sublineages, A1, A2, A3, B1, and B2, the distribution of which varied by geographical region. Among 192 cases of cervical cancer and 101 controls, the B2 sublineage was significantly overrepresented in cervical cancer, both overall and in Africa and Europe separately. We show that the sequence analysis of E6 and E7 allows the classification of HPV45 variants and that the risk of cervical cancer may differ by HPV45 variant sublineage.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/33154
Referências
  1. Alibegashvili T, 2011, CANCER EPIDEMIOL, V35, P465, DOI 10.1016/j.canep.2010.12.006
  2. Aruhuri B, 2012, CANCER PREV RES, V5, P746, DOI 10.1158/1940-6207.CAPR-11-0515
  3. Bardin A, 2008, EUR J CANCER, V44, P557, DOI 10.1016/j.ejca.2007.12.001
  4. Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008
  5. Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
  6. Berumen J, 2001, J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325
  7. BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
  8. Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8
  9. Chen AA, 2014, VIROLOGY, V448, P356, DOI 10.1016/j.virol.2013.10.033
  10. Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183
  11. Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072565
  12. Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08
  13. Clifford G, 2008, INT J CANCER, V122, P1684, DOI 10.1002/ijc.23282
  14. Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9
  15. Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508
  16. Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12
  17. de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
  18. De Vuyst H, 2012, INT J CANCER, V131, P949, DOI 10.1002/ijc.26470
  19. Dondog B, 2008, CANCER EPIDEM BIOMAR, V17, P1731, DOI 10.1158/1055-9965.EPI-07-2796
  20. FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941
  21. Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350
  22. Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187
  23. Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011
  24. Guan P, 2013, INT J CANCER, V132, P248, DOI 10.1002/ijc.27663
  25. Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485
  26. Hammouda D, 2005, INT J CANCER, V113, P483, DOI 10.1002/ijc.20600
  27. Hesselink AT, 2009, INT J CANCER, V124, P381, DOI 10.1002/ijc.23940
  28. Keita N, 2009, BRIT J CANCER, V101, P202, DOI 10.1038/sj.bjc.6605140
  29. Khodakarami N, 2012, INT J CANCER, V131, pE156, DOI 10.1002/ijc.26488
  30. Li LK, 2006, BRIT J CANCER, V95, P1593, DOI 10.1038/sj.bjc.6603450
  31. Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396
  32. Liu Y, 1999, J VIROL, V73, P7297
  33. Mbaye EHS, 2014, J MED VIROL, V86, P248, DOI 10.1002/jmv.23719
  34. Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
  35. NAGHASHFAR ZS, 1987, J GEN VIROL, V68, P3073, DOI 10.1099/0022-1317-68-12-3073
  36. Ntova CK, 2012, INT J MOL SCI, V13, P1, DOI 10.3390/ijms13010001
  37. Sathish N, 2005, CANCER LETT, V229, P93, DOI 10.1016/j.canlet.2005.04.026
  38. Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
  39. Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z
  40. Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153
  41. van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002
  42. Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959
  43. Wu RF, 2007, INT J CANCER, V121, P1306, DOI 10.1002/ijc.22726
  44. Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - ODS/03